The study confirmed no abnormal challenges, which indicated that it could be safely administered in just a medical research context. Later on, Dr. Charles Grob requested permission to more study the material with cancer individuals, but was denied by the FDA 2 times.The 1st report with the synthesis of copyright in the peer-reviewed literature was